Revolutionary device decodes RNA for faster diagnosis of cancer
HQ Team October 26, 2023: Scientists at the University of Notre Dame have developed an innovative device that can decode the messages exchanged
Drugs
Health
Pharma
BioMarin’s achondroplasia drug gets nod for children of all ages
HQ Team October 21, 2023: The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children
Drugs
Health
Pharma
Pfizer’s vaccine for meningococcal disease gets FDA approval
HQ Team October 21, 2023: The USFDA has approved Pfizer Inc.’s vaccine to treat deadly meningococcal disease in young adults between 10 years
Drugs
Health
Medical
Role of fructose in obesity, a new perspective
HQ Team October 20, 2023: A new research paper suggests that fructose, a type of sugar, maybe a significant driver of obesity. While
Drugs
Health
Medical
Innovative magnetic gel accelerates diabetic wound healing
HQ Team October 20, 2023: More than half a billion people worldwide are living with diabetes, and this number is expected to rise.
Drugs
Health
Pharma
Scientists connect gut microbiota to Alzheimer’s disease in lab experiments
HQ Team October 19, 2023: Experiments conducted on young adult rats have established a link between Alzheimer’s and gut microbiota, according to a
Drugs
Health
Pharma
Belgium’s Hyloris gets nod for post-operative pain reduction drug
HQ Team October 18, 2023: Hyloris Pharmaceuticals SA, Liège, Belgium-based biopharma company, announced the US Food and Drug Administration has approved its post-operative
Drugs
Health
Pharma
Novo Nordisk to buy hypertension drug from KBP for $1.3 billion
HQ Team October 16, 2023: Danish pharmaceutical company, Novo Nordisk, announced it was buying a hypertension drug, still in trials, from Singapore-based KBP
Drugs
Health
Pharma
BioNTech expects revenue to be lower in 2023 as Covid-19 vaccine sales fall
HQ Team October 16, 2023: Germany’s BioNTech announced its partner Pfizer Inc.’s write-offs for inventory and other charges related to the Covid-19 Comirnaty
Drugs
Health
Pharma
ImmunoACT gets nod for leukaemia, lymphoma cancer therapy in India
HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to